Nek7 conformational flexibility and inhibitor binding probed through protein engineering of the R-spine

Matthew J Byrne1, Nazia Nasir1, Christine Basmadjian2

  • 1Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, U.K.

Insights

Researchers engineered a Nek7 kinase mutant to stabilize its active form, aiding in the development of novel cancer therapeutics by facilitating inhibitor complex crystallization.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Cancer Therapeutics

Background:

  • Nek7 (Never in mitosis gene A-related kinase 7) is a kinase crucial for cell division.
  • Elevated Nek7 levels are linked to various cancers, making it a potential therapeutic target.
  • Lack of selective and potent Nek7 inhibitors hinders drug development.

Purpose of the Study:

  • To develop a strategy for obtaining high-resolution crystal structures of Nek7 in complex with inhibitors.
  • To stabilize the active conformation of Nek7 for structural studies.
  • To identify key structural features for designing selective Nek family inhibitors.

Main Methods:

  • Introduction of aromatic residues into the Nek7 regulatory-spine (R-spine) to create a 'strong R-spine' mutant (Nek7SRS).
  • Crystallization of Nek7SRS and wild-type Nek7 (Nek7WT) in apo and inhibitor-bound forms.
  • X-ray crystallography to determine the structures of Nek7 complexes.
  • Comparative analysis of inhibitor binding modes across Nek family members.

Main Results:

  • The Nek7SRS mutant retained catalytic activity and facilitated crystallization of Nek7-inhibitor complexes.
  • Crystal structures revealed stabilized R-spine conformations in Nek7SRS compared to Nek7WT.
  • Compound 51, an ATP-competitive inhibitor, bound to both Nek7 and Nek2.
  • Structural analysis identified subtle differences in inhibitor binding that could be exploited for selectivity.

Conclusions:

  • Engineering the R-spine is a viable strategy to stabilize active kinase conformations and promote crystallogenesis.
  • This approach aids in obtaining structures of challenging targets like Nek7.
  • Structural insights provide a foundation for designing selective Nek family kinase inhibitors for cancer therapy.